Trial Profile
Efficacy and safty of tenofovir alafenamide treatment swithed from entecavir in patinets with chronic hepatitis B.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2020
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Apr 2020 Status changed to discontinued.
- 04 Jul 2018 New trial record